Voyager Therapeutics, Inc.
VYGR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$65,002 | $132,330 | -$46,408 | -$71,197 |
| Dep. & Amort. | $4,731 | $4,441 | $6,191 | $5,165 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $14,785 | $11,153 | $0 | $0 |
| Change in WC | $34,859 | -$66,557 | $20,471 | $3,294 |
| Other Non-Cash | -$4,683 | -$3,448 | $7,237 | $9,213 |
| Operating Cash Flow | -$15,310 | $77,919 | -$12,509 | -$53,525 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,521 | -$3,256 | -$2,491 | -$1,609 |
| Net Acquisitions | $0 | $138,387 | $0 | $0 |
| Inv. Purchases | -$465,685 | -$223,968 | -$54,848 | -$15,117 |
| Inv. Sales/Matur. | $374,347 | $85,581 | $50,000 | $82,632 |
| Other Inv. Act. | $0 | -$138,387 | $0 | $0 |
| Investing Cash Flow | -$94,859 | -$141,643 | -$7,339 | $65,906 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $112,778 | $31,121 | $1,110 | $612 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,237 | $2,524 | $0 | $0 |
| Financing Cash Flow | $114,015 | $33,645 | $1,110 | $612 |
| Forex Effect | $0 | $0 | $264 | $0 |
| Net Chg. in Cash | $3,846 | -$30,079 | -$18,474 | $12,993 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $70,395 | $100,474 | $117,433 | $104,440 |
| End Cash | $74,241 | $70,395 | $98,959 | $117,433 |
| Free Cash Flow | -$18,831 | $74,663 | -$15,000 | -$55,134 |